Market News AIOpen the app

INTS stock news · Intensity Therapeutics

Stories about Intensity Therapeutics (INTS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for INTS

Follow Intensity Therapeutics (INTS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for INTS
Free on the App Store and Google Play, or on the web.
  1. Oct 30, 2026, 8:14 AM ET · Market

    12 health care stocks are changing in price before the market opens, with NRX Pharmaceuticals going up and Acumen Pharmaceuticals dropping.

    Neutral

    Intensity Therapeutics shares rose about 10% before Friday's trading. The report gives no new company news, so the share move does not change its business outlook.

  2. Oct 23, 2026, 9:14 AM ET · Market

    Intensity Therapeutics shared good early results from its INVINCIBLE-4 study on INT230-6.

    Good for INTS

    Intensity Therapeutics reported encouraging early results for its cancer drug alongside standard treatment. The small group limits certainty, but the patient results support a positive read for the company.

  3. Oct 14, 2026, 5:18 PM ET · Market

    12 health care stocks changed a lot in prices after the market closed on Wednesday.

    Neutral

    Intensity Therapeutics shares fell 10.82% to $3.05 after hours, but the report gives no company news, so the business view is unchanged.